The neurobiology of schizophrenia involves multiple facets of pathophysiology, ranging from
its genetic basis over changes in neurochemistry and neurophysiology, to the systemic level …

Research into the neurobiological processes that may lead to the onset of schizophrenia
places growing emphasis on the glutamatergic system and brain development. Preclinical …

Schizophrenia (SZ) is a neurodevelopmental disorder with cognitive deficits manifesting
during early stages of the disease. Evidence suggests that genetic factors in combination …

Schizophrenia is a severe mental disorder with unknown etiology. Many mechanisms,
including dysregulation of neurotransmitters, immune disturbance, and abnormal …

The importance of interactions between the brain and the gastrointestinal tract has been
increasingly recognized in recent years. It has been proposed that dysregulation and …

Bisphenol A (BPA) is a chemical endocrine disruptor to which humans are often exposed in
daily life. Postnatal administration of BPA results in schizophrenia (SCZ)-like behaviours in …

Schizophrenia (SCZ) is characterized not only by psychosis, but also by working memory
and executive functioning deficiencies, processes that rely on the prefrontal cortex (PFC) …

Major depressive disorder (MDD) represents a complex and challenging mental health
condition with multifaceted etiology. Recent research exploring the gut-brain axis has shed …

We investigated the genome of a 5-year-old male who presented with global developmental
delay (motor, cognitive, and speech), hypotonia, possibly ataxia, and cerebellar hypoplasia …

Prodromal memory deficits represent an important marker for the development of
schizophrenia (SZ), in which glutamatergic hypofunction occurs in the prefrontal cortex …